FdaApplication
ANDA 206617
Identifiers
- fda_app_no: ANDA206617
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA INTERNATIONAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2021-06-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | EQ 200MG BASE/VIAL | INJECTABLE;INJECTION |
| GEMCITABINE HYDROCHLORIDE | GEMCITABINE HYDROCHLORIDE | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
2 products